A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Dr. Valerie Truesdale Joins The Goddard School’s Educational Advisory Board
SEC enforcement chief rejects criticism of crypto crackdown
Glencore Bets on US Love of Coal With New Fossil Fuel Giant
In major blow to TikTok, Indonesia bans e-commerce transactions on social media
Former Twitter employee says working for Elon Musk was ‘hardest experience of her life’
Europe Dominates Climate Fund Investing
Storm May Dump a Foot of Snow in Western New York: Weather Watch
Jose Hidalgo Named President of FTI as Company Rises to Solve New Challenges in Defense Industry